Medical device regulations in Europe and in the US are currently undergoing a major transformation. As the global regulatory landscape is shifting, approval pathways for medical device innovations may become more burdensome yet new regulations may create alternative strategies. As regulatory requirements change, and markets evolve, companies need to carefully define and execute their clinical and regulatory strategies. In this dynamic regulatory framework, it is critical for medical device start-ups to bring their clinical and regulatory strategy into focus early in the development phase. Difficult questions must be faced to  define an effective regulatory roadmap. Thuja Capital and Maxis Medical invite you to learn about opportunities and pitfalls in building a solid, global regulatory strategy. Expert faculty will educate you on regulatory frameworks and share their best practices with you. The symposium on Regulatory Strategy in Medical Innovation will take place on March 21, 2019 in Utrecht, Netherlands.